146 related articles for article (PubMed ID: 12111696)
1. Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts.
Rice L; Samedi VG; Medrano TA; Sweeney CA; Baker HV; Stenstrom A; Furman J; Shiverick KT
Prostate; 2002 Aug; 52(3):201-12. PubMed ID: 12111696
[TBL] [Abstract][Full Text] [Related]
2. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
3. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
[TBL] [Abstract][Full Text] [Related]
4. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways.
Huynh H; Nguyen TH; Panasci L; Do P
Cancer; 2004 Dec; 101(12):2881-91. PubMed ID: 15529313
[TBL] [Abstract][Full Text] [Related]
5. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest.
Chiao JW; Wu H; Ramaswamy G; Conaway CC; Chung FL; Wang L; Liu D
Carcinogenesis; 2004 Aug; 25(8):1403-8. PubMed ID: 15016658
[TBL] [Abstract][Full Text] [Related]
6. Silvestrol regulates G2/M checkpoint genes independent of p53 activity.
Mi Q; Kim S; Hwang BY; Su BN; Chai H; Arbieva ZH; Kinghorn AD; Swanson SM
Anticancer Res; 2006; 26(5A):3349-56. PubMed ID: 17094452
[TBL] [Abstract][Full Text] [Related]
7. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
[TBL] [Abstract][Full Text] [Related]
8. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
[TBL] [Abstract][Full Text] [Related]
9. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
10. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells.
Davis JN; Singh B; Bhuiyan M; Sarkar FH
Nutr Cancer; 1998; 32(3):123-31. PubMed ID: 10050261
[TBL] [Abstract][Full Text] [Related]
11. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
Srivastava SK; Xiao D; Lew KL; Hershberger P; Kokkinakis DM; Johnson CS; Trump DL; Singh SV
Carcinogenesis; 2003 Oct; 24(10):1665-70. PubMed ID: 12896904
[TBL] [Abstract][Full Text] [Related]
12. Anti-prostate cancer activity of a beta-carboline alkaloid enriched extract from Rauwolfia vomitoria.
Bemis DL; Capodice JL; Gorroochurn P; Katz AE; Buttyan R
Int J Oncol; 2006 Nov; 29(5):1065-73. PubMed ID: 17016636
[TBL] [Abstract][Full Text] [Related]
13. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
[TBL] [Abstract][Full Text] [Related]
14. Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells.
Sun XY; Plouzek CA; Henry JP; Wang TT; Phang JM
Cancer Res; 1998 Jun; 58(11):2379-84. PubMed ID: 9622078
[TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
16. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
17. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer.
Su SJ; Yeh TM; Lei HY; Chow NH
Clin Cancer Res; 2000 Jan; 6(1):230-6. PubMed ID: 10656454
[TBL] [Abstract][Full Text] [Related]
18. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
20. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]